Great Point Partners LLC Portfolio Holdings

Great Point Partners LLC

  • $127 Million
  • Q3 2025

Great Point Partners LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $127 Million distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Amylyx Pharmaceuticals, Inc. with a value of $23.1M, Rezolute, Inc. with a value of $22.8M, Ascendis Pharma A/S with a value of $14.9M, Immunovant, Inc. with a value of $13.8M, and Cytokinetics Inc with a value of $8.24M.

Examining the 13F form we can see an increase of $6.42M in the current position value, from $121M to 127M.

Great Point Partners LLC is based out at Greenwich, CT

Below you can find more details about Great Point Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $127 Million
Healthcare: $127 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$18.5M
$4.54 Million 3.58% of portfolio
4,683,711
Q4 2024 Reduced 32.46%

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $127 Million
  • Prior Value $121 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 10 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email